Robot Surgeons Coming Soon, to a Future Battlefield Near You
Technology can bring modern medicine anywhere in the world, if the phone system is working, but humans have to remain in control, says Technion professor Alon Wolf Breakthrough device helps MRI take better snapshot [...]
Wave of the future – cutting and pasting genes
Israeli scientists are being introduced to a new technique to cure some genetic diseases by a Tel Aviv University biologist and geneticist. Anyone familiar with a word-processing program has much experience cutting and pasting for [...]
IATI Biomed 2016 Call for abstracts! Deadline extension
Call for Abstracts Deadline extended for Oral Company Presentations till April 10 at IATI Biomed 2016 Dear Colleagues, IATI Biomed 2016 is the premier life sciences event providing a meeting place for the healthcare’s industry players [...]
BioBlast Pharma Announces Positive Final Results from HOPEMD Phase 2 Open-Label Clinical Study of Trehalose 90mg/mL IV Solution in Oculopharyngeal Muscular Dystrophy (OPMD)
NEW HAVEN, Conn., March 16, 2016 (GLOBE NEWSWIRE) -- BioBlast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, announced positive results from its HOPEMD Phase 2 six-month open-label clinical study in patients with oculopharyngeal [...]
Emerald melanoma diagnosis system wins FDA approval
The company already has distribution agreements in Israel, Sweden, Australia, and New Zealand. The system developed by Israeli company Emerald Medical Applications (OTC: MRLA), formerly DermaCare, which is designed to diagnose melanoma, has been [...]
IATI Biomed 2016 Call for startups! Submission Deadline
The Start-up Pavilion Submission Deadline is March 22nd, 2016 If you’re an innovative early stage Biomed start-up, this is for you! One of the highlights of the IATI Biomed Exhibition is the Start-up Pavilion, dedicated [...]